This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08938/identifier/wikipedia/
foafhttp://xmlns.com/foaf/0.1/
n7http://linked.opendata.cz/resource/drugbank/mixture/
n11http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB08938/identifier/kegg-drug/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08938/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://www.drugs.com/international/

Statements

Subject Item
n2:DB08938
rdf:type
n3:Drug
n3:description
Magaldrate is an antacid drug used for the treatment of esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. Magaldrate has been discontinued in the US market.
n3:generalReferences
# Kurtz W: [A layered lattice antacid with long-term effectiveness. Profile of action and safety exemplified by magaldrate]. Fortschr Med. 1993 Feb 28;111(6):93-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8462913 # Varas Lorenzo MJ, Lopez Martinez A, Gordillo Bernal J, Mundet Surroca J: [Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer]. Rev Esp Enferm Dig. 1991 Aug;80(2):91-4. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/1790087
n3:group
withdrawn
owl:sameAs
n11:DB08938
dcterms:title
Magaldrate
adms:identifier
n6:D04832 n8:Magaldrate n9:DB08938
n3:routeOfElimination
Aluminium oxide: absorbed Al ions are eliminated in the urine (0.1-0.5 mg of Al in aluminium-containing antacid is absorbed from standard daily doses of antacid) while insoluble or poorly absorbed Al salts in the intestines are excreted through the feces. Magnesium oxide: absorbed Mg ions (up to 30%) are eliminated in the urine, unabsorbed is excreted in the feces.
n3:synonym
Magaldrato Aluminum magnesium hydroxide hydrate Magaldratum
n3:mixture
n7:271B5E31-363D-11E5-9242-09173F13E4C5 n7:271B5E2E-363D-11E5-9242-09173F13E4C5 n7:271B5E2F-363D-11E5-9242-09173F13E4C5 n7:271B5E32-363D-11E5-9242-09173F13E4C5 n7:271B5E33-363D-11E5-9242-09173F13E4C5 n7:271B5E2D-363D-11E5-9242-09173F13E4C5 n7:271B5E30-363D-11E5-9242-09173F13E4C5
n3:synthesisReference
U.S. Patent 2,923,660.
foaf:page
n13:magaldrate.html
n3:IUPAC-Name
n4:271B5E35-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5E3B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5E3A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5E37-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5E38-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5E39-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5E34-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5E41-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5E42-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5E3C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5E3D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5E3F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5E3E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5E40-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
1317-26-6
n3:Bioavailability
n4:271B5E45-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5E47-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5E48-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5E44-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5E43-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5E46-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5E36-363D-11E5-9242-09173F13E4C5